Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case report

BACKGROUND: Small cell lung cancer (SCLC) transformation is one of the resistance mechanisms associated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). Rechallenge with the first-line TKI after the second-line chemotherapy is suggested as a salvage treatment despite m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sanghun, Joo, Jeonghyun, Kwak, Minah, Sohn, Kicheul, Chon, Songha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042494/
https://www.ncbi.nlm.nih.gov/pubmed/30022837
http://dx.doi.org/10.2147/OTT.S164764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042494/
https://www.ncbi.nlm.nih.gov/pubmed/30022837
http://dx.doi.org/10.2147/OTT.S164764

Ejemplares similares